Choroidal neovascularisation in pathological myopia: an update in management

Area of Science:

• Ophthalmology
• Retinal Diseases
• Myopia Research

Background:

• Choroidal neovascularisation (CNV) secondary to pathological myopia is a leading cause of vision impairment in young and middle-aged adults.
• This condition is particularly prevalent in Asian populations, highlighting a significant global health concern.
• Recent years have seen substantial progress in therapeutic strategies for myopic CNV.

Purpose of the Study:

• To provide a comprehensive overview of the natural history of myopic CNV.
• To review and discuss various treatment modalities currently available for myopic CNV.
• To explore future directions and advancements in the management of pathological myopia-induced CNV.

Main Methods:

• Literature review of existing studies on myopic CNV.
• Analysis of current treatment options including laser photocoagulation, photodynamic therapy, sub-macular surgery, and macular translocation.
• Discussion of the natural progression and outcomes associated with myopic CNV.

Main Results:

• Myopic CNV presents a significant challenge due to its impact on visual acuity.
• A range of treatments exist, each with specific indications and outcomes.
• Understanding the natural history is crucial for effective management.

Conclusions:

• Effective management of myopic CNV requires a thorough understanding of its natural course and available treatments.
• Continued research into novel therapeutic approaches is essential for improving patient outcomes.
• Future strategies will likely involve a combination of existing and emerging treatments tailored to individual patient needs.